Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Kenvue Inc. (KVUE : NYSE)

• Company Description    Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J. Number of Employees: 22,000

• Price / Volume Information    Yesterday's Closing Price: $18.85 Daily Weekly Monthly 20 Day Moving Average: 23,182,142 shares Shares Outstanding: 1,919.07 (millions) Market Capitalization: $36,174.47 (millions) Beta: 0.83 52 Week High: $25.17 52 Week Low: $17.15 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -10.49% -12.11% 12 Week -11.75% -19.88% Year To Date -11.71% -21.17%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1 KENVUE WAY - SUMMIT,NJ 07901 USA ph: 908-874-1200 fax: - kenvue_ir@kenvue.com http://www.kenvue.com

• General Corporate Information    Officers Thibaut Mongon - Chief Executive Officer and Director Larry J. Merlo - Chair of the Board Paul Ruh - Chief Financial Officer Richard E. Allison - Director Tamara S. Franklin - Director Peer Information Kenvue Inc. (EPC) Kenvue Inc. (HPPS) Kenvue Inc. (ADRNY) Kenvue Inc. (YHGJ) Kenvue Inc. (GPSYY) Kenvue Inc. (HENKY) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: CONS PD- MISC STPL Sector: Consumer Staples CUSIP: 49177J102 SIC: 2844 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/06/25 Share - Related Items Shares Outstanding: 1,919.07 Most Recent Split Date: (:1) Beta: 0.83 Market Capitalization: $36,174.47 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 4.40% Current Fiscal Quarter EPS Consensus Estimate: $0.27 Indicated Annual Dividend: $0.83 Current Fiscal Year EPS Consensus Estimate: $0.99 Payout Ratio: 0.77 Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 7.00% Last Dividend Paid: 08/13/2025 - $0.21 Next EPS Report Date: 11/06/25

• Fundamental Ratios P/E Current FY Estimate: 18.95 Trailing 12 Months: 17.62 PEG Ratio: 2.71 Price Ratios Price/Book: 3.37 Price/Cash Flow: 12.81 Price / Sales: 2.39 EPS Growth vs. Year Ago Period: -9.38% vs. Previous Quarter: 20.83% Sales Growth vs. Year Ago Period: -4.03% vs. Previous Quarter: 2.62% ROE 06/30/25 - 20.06 03/31/25 - 20.87 12/31/24 - 21.38 ROA 06/30/25 - 7.78 03/31/25 - 8.04 12/31/24 - 8.27 Current Ratio 06/30/25 - 0.98 03/31/25 - 0.86 12/31/24 - 0.96 Quick Ratio 06/30/25 - 0.68 03/31/25 - 0.60 12/31/24 - 0.69 Operating Margin 06/30/25 - 13.61 03/31/25 - 13.83 12/31/24 - 14.22 Net Margin 06/30/25 - 9.37 03/31/25 - 6.90 12/31/24 - 6.66 Pre-Tax Margin 06/30/25 - 13.00 03/31/25 - 9.45 12/31/24 - 9.16 Book Value 06/30/25 - 5.59 03/31/25 - 5.24 12/31/24 - 5.04 Inventory Turnover 06/30/25 - 3.70 03/31/25 - 3.70 12/31/24 - 3.64 Debt-to-Equity 06/30/25 - 0.66 03/31/25 - 0.63 12/31/24 - 0.73 Debt-to-Capital 06/30/25 - 39.67 03/31/25 - 38.56 12/31/24 - 42.19

Powered by Zacks Investment Research ©